Androgenetic Alopecia Market Size, Share & Trends Report

Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-197-2
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Androgenetic Alopecia Gender Outlook (Revenue, USD Million, 2018 - 2030)
- Male
- Female
Androgenetic Alopecia Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceuticals
- Devices
Androgenetic Alopecia End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Dermatology Clinics
- Homecare Settings
Androgenetic Alopecia Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Prescriptions
- OTC
Androgenetic Alopecia Regional Outlook (Number of Patients Treated in Thousands; Revenue, USD Million, 2018 - 2030)
- North America
  - North America Gender Outlook (Revenue in USD Million, 2018 - 2030)
    - Male
    - Female
  - North America Treatment Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceuticals
    - Devices
  - North America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Dermatology Clinics
    - Homecare Settings
  - North America Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Prescription
    - OTC
  - U.S.
    - U.S. Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - U.S. Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - U.S. End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - U.S. Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Canada
    - Canada Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Canada Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Canada End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Canada Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
- Europe
  - Europe Gender Outlook (Revenue in USD Million, 2018 - 2030)
    - Male
    - Female
  - Europe Treatment Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceuticals
    - Devices
  - Europe End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Dermatology Clinics
    - Homecare Settings
  - Europe Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Prescription
    - OTC
  - Germany
    - Germany Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Germany Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Germany End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Germany Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - UK
    - UK Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - UK Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - UK End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - UK Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - France
    - France Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - France Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - France End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - France Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Italy
    - Italy Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Italy Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Italy End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Italy Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Spain
    - Spain Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Spain Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Spain End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Spain Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Denmark
    - Denmark Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Denmark Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Denmark End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Denmark Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Sweden
    - Sweden Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Sweden Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Sweden End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Sweden Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Norway
    - Norway Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Norway Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Norway End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Norway Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
- Asia Pacific
  - Asia Pacific Gender Outlook (Revenue in USD Million, 2018 - 2030)
    - Male
    - Female
  - Asia Pacific Treatment Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceuticals
    - Devices
  - Asia Pacific End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Dermatology Clinics
    - Homecare Settings
  - Asia Pacific Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Prescription
    - OTC
  - China
    - China Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - China Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - China End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - China Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Japan
    - Japan Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Japan Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Japan End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Japan Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - India
    - India Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - India Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - India End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - India Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Thailand
    - Thailand Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Thailand Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Thailand End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Thailand Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - South Korea
    - South Korea Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - South Korea Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - South Korea End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - South Korea Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Australia
    - Australia Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Australia Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Australia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Australia Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
- Latin America
  - Latin America Gender Outlook (Revenue in USD Million, 2018 - 2030)
    - Male
    - Female
  - Latin America Treatment Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceuticals
    - Devices
  - Latin America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Dermatology Clinics
    - Homecare Settings
  - Latin America Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Prescription
    - OTC
  - Brazil
    - Brazil Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Brazil Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Brazil End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Brazil Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Mexico
    - Mexico Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Mexico Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Mexico End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Mexico Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Argentina
    - Argentina Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Argentina Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Argentina End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Argentina Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
- Middle East and Africa
  - Middle East and Africa Gender Outlook (Revenue in USD Million, 2018 - 2030)
    - Male
    - Female
  - Middle East and Africa Treatment Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceuticals
    - Devices
  - Middle East and Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Dermatology Clinics
    - Homecare Settings
  - Middle East and Africa Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Prescription
    - OTC
  - South Africa
    - South Africa Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - South Africa Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - South Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - South Africa Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Saudi Arabia
    - Saudi Arabia Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Saudi Arabia Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Saudi Arabia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Saudi Arabia Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - UAE
    - UAE Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - UAE Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - UAE Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC
  - Kuwait
    - Kuwait Gender Outlook (Revenue in USD Million, 2018 - 2030)
      - Male
      - Female
    - Kuwait Treatment Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceuticals
      - Devices
    - Kuwait End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Dermatology Clinics
      - Homecare Settings
    - Kuwait Sales Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Prescription
      - OTC

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.